Efficacy and Safety of Reteplase for Central Venous Catheter Occlusion in Patients with Cancer
Authors:
- Chin Y. LiuCLChin Y. Liu
- Vikash JainVJVikash Jain
- Anthony F. ShieldsASAnthony F. Shields
- Lance K. HeilbrunLHLance K. Heilbrun
- 1 January 2004
- journal article
- clinical trial
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 15 (1) , 39-44
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Safety and Efficacy of Alteplase for Restoring Function in Occluded Central Venous Catheters: Results of the Cardiovascular Thrombolytic to Open Occluded Lines TrialJournal of Clinical Oncology, 2002
- Recombinant Tissue Plasminogen Activator (Alteplase) for Restoration of Flow in Occluded Central Venous Access Devices: A Double-Blind Placebo-Controlled Trial—The Cardiovascular Thrombolytic to Open Occluded Lines (COOL) Efficacy TrialJournal of Vascular and Interventional Radiology, 2001
- Incidence and Management of Catheter Occlusion in Implantable Arm Ports: Results in 391 PatientsJournal of Vascular and Interventional Radiology, 1999
- Thrombotic Complications of Central Venous Catheters in Cancer PatientsSeminars in Thrombosis and Hemostasis, 1999
- Prevention and management of central venous catheter thrombosisCurrent Opinion in Hematology, 1998
- Treatment of Central Venous Catheter Occlusions With Ethanol and Hydrochloric AcidJournal of Parenteral and Enteral Nutrition, 1995
- Urokinase versus Recombinant Tissue Plasminogen Activator in Thrombosed Central Venous Catheters:Thrombosis and Haemostasis, 1994
- Investigational Use of Tissue Plasminogen Activator (t‐PA) for Occluded Central Venous CathetersJournal of Parenteral and Enteral Nutrition, 1990
- Optimal two-stage designs for phase II clinical trialsControlled Clinical Trials, 1989
- Refining binomial confidence intervalsCanadian Journal of Statistics, 1986